United States · FDA National Drug Code directory
BUPIVACAINE HCI AND EPINEPHRINE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 51662-1399_10328ddf-6e3b-c9e0-e063-6294a90a52ed
- Product NDC
- 51662-1399
- Form
- INJECTION, SOLUTION
- Composition / generic term
- BUPIVACAINE HCI AND EPINEPHRINE
- Labeler
- HF Acquisition Co LLC, DBA HealthFirst
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20191209
- Source listing expiry
- 20261231
Source-listed ingredients
- BUPIVACAINE HYDROCHLORIDE — 5 mg/mL
- EPINEPHRINE BITARTRATE — .005 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 50 mL in 1 VIAL, MULTI-DOSE (51662-1399-1) · 51662-1399-1
- 1 VIAL, MULTI-DOSE in 1 POUCH (51662-1399-2) / 50 mL in 1 VIAL, MULTI-DOSE · 51662-1399-2
- 25 POUCH in 1 CASE (51662-1399-3) / 1 VIAL, MULTI-DOSE in 1 POUCH / 50 mL in 1 VIAL, MULTI-DOSE · 51662-1399-3
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →